NCT05501704
ETHAN - ET for Male BC treatment 2 recruiting NCT01037790
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer treatment 2 completed NCT01869764
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer treatment 2 completed NCT02046421
Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT00132002
Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer treatment 2 terminated NCT01372579
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients treatment 2 unknown_status NCT02480933
Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens No drug interventions diagnostic Not Available unknown_status NCT00024154
Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT02060253
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer treatment 1 completed NCT01245205
Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer treatment 1 completed NCT00098605
Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases treatment 2 completed NCT01288261
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer treatment 1 completed NCT01394211
Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer treatment 2 terminated NCT00095888
3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer treatment 2 terminated NCT00068588
GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT00559507
Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT01931709
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer No drug interventions diagnostic Not Available terminated NCT00343109
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer prevention 2 completed NCT00030615
Decitabine in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00791037
Vaccine Therapy in Treating Patients With Stage IV Breast Cancer treatment 1 / 2 completed NCT01632332
Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer treatment 1 completed NCT00331552
Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer treatment 1 / 2 completed NCT01104259
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer treatment 1 completed NCT01806675
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy diagnostic 1 / 2 completed NCT00368875
Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer treatment 1 / 2 completed NCT00071942
Vaccine Therapy in Treating Patients With Metastatic Breast Cancer No drug interventions treatment 1 terminated NCT00003199
Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer treatment 2 completed NCT00348699
AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery No drug interventions treatment 1 completed NCT00005817
Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer treatment 2 completed NCT00096434
Sorafenib in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT00063934
Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer treatment 1 / 2 terminated NCT00028496
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer treatment 1 completed NCT01042535
Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer treatment 1 / 2 completed NCT01084057
Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer treatment 1 completed NCT01158274
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors treatment 1 completed NCT01703520
Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021). No drug interventions Not Available Not Available completed NCT00937482
Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer treatment 1 terminated NCT00017394
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer treatment 2 completed NCT01982591
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy No drug interventions Not Available Not Available completed NCT00119262
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer treatment 2 completed NCT00089362
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors treatment 1 completed NCT03018080
Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer treatment 2 completed NCT02013492
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery treatment 0 completed NCT00470301
Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer treatment 1 / 2 completed NCT01153672
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy treatment Not Available completed NCT01493310
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer treatment 1 completed NCT00244881
A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202) treatment 2 completed NCT01868503
Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer treatment 2 terminated NCT00821964
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer treatment 2 completed NCT01720602
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy treatment Not Available completed NCT01729884
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer treatment 2 terminated NCT01938833
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer treatment 1 / 2 terminated NCT01222377
Endoscopic Breast Surgery in Treating Patients With Breast Cancer No drug interventions treatment Not Available terminated NCT01638247
Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients treatment 3 completed NCT00030498
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction treatment 1 completed NCT00098397
FR901228 in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT01939483
A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases treatment Not Available withdrawn NCT00006228
Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT01217411
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer treatment 1 terminated NCT01355393
Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer treatment 1 / 2 completed NCT00045188
Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT01219907
Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer treatment 1 withdrawn NCT01783756
Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis treatment 1 / 2 completed NCT01706432
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer No drug interventions Not Available Not Available completed NCT05156606
Testosterone & Tamoxifen Trial treatment Not Available terminated NCT00258349
Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer treatment 1 / 2 completed NCT01151449
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer treatment 2 terminated NCT01155258
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors treatment 1 completed NCT00028535
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors treatment 1 completed NCT00343863
Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer supportive_care Not Available completed NCT02580448
CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) treatment 1 / 2 completed NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu treatment 1 completed NCT00077376
Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer treatment 2 completed NCT01100489
Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer No drug interventions treatment 2 withdrawn NCT01705340
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery treatment 1 terminated NCT00425672
ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment treatment 1 / 2 completed NCT03240510
Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience No drug interventions Not Available Not Available unknown_status NCT00513695
Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer treatment 2 completed NCT00039455
Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer treatment 1 terminated NCT03112590
Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer treatment 1 / 2 completed NCT03387553
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer No drug interventions treatment 0 active_not_recruiting NCT03295695
PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient No drug interventions supportive_care 0 withdrawn NCT03384914
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer No drug interventions treatment 2 active_not_recruiting NCT03630809
Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1 No drug interventions treatment 2 terminated NCT03800355
Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk No drug interventions Not Available Not Available completed NCT02586675
TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer treatment 1 completed